Royal Bank of Canada’s Signify Health, Inc. SGFY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-391,180
Closed -$11.2M 7745
2022
Q4
$11.2M Buy
391,180
+351,390
+883% +$10.1M ﹤0.01% 1527
2022
Q3
$1.16M Buy
39,790
+35,782
+893% +$824K ﹤0.01% 3325
2022
Q2
$55K Sell
4,008
-1,319
-25% -$18.6K ﹤0.01% 5676
2022
Q1
$97K Buy
5,327
+288
+6% +$4.13K ﹤0.01% 5680
2021
Q4
$71K Buy
5,039
+1,211
+32% +$18.7K ﹤0.01% 6176
2021
Q3
$68K Sell
3,828
-45,244
-92% -$1.16M ﹤0.01% 5977
2021
Q2
$1.49M Buy
49,072
+3,188
+7% +$87.6K ﹤0.01% 3313
2021
Q1
$1.34M Buy
+45,884
New +$1.42M ﹤0.01% 3331

Other funds holding SGFY

Royal Bank of Canada's SGFY Position: Q1 2023 in Review

Royal Bank of Canada sold out of Signify Health, Inc. (SGFY) in Q1 2023, closing a stake of 391,180 shares — an estimated $11.2M sold.

Royal Bank of Canada first reported a position in SGFY in Q1 2021 and held it in 8 quarters. The position peaked at $11.2M in Q4 2022. 5 funds tracked by Wall St. Rank hold SGFY as of Q1 2023.

  • Royal Bank of Canada reported no remaining Signify Health, Inc. position as of Q1 2023 after selling out during the quarter.
  • Royal Bank of Canada sold 391,180 Signify Health, Inc. shares in Q1 2023, an estimated $11.2M.
  • Royal Bank of Canada first reported a position in Signify Health, Inc. in Q1 2021 and held it in 8 quarters.
  • Royal Bank of Canada's Signify Health, Inc. position peaked at $11.2M in Q4 2022.
  • 5 funds tracked by Wall St. Rank held Signify Health, Inc. as of Q1 2023.

Based on Royal Bank of Canada's 13F filing for Q1 2023, filed 15 May 2023.